[144] Marvell Technology, Inc. SEC Filing

Rhea-AI Filing Summary

Marvell Technology, Inc. (MRVL) Form 144 notifies a proposed sale of 1,500 shares of common stock through Morgan Stanley Smith Barney LLC with an approximate sale date of 09/15/2025 on NASDAQ. The shares were acquired as performance shares from the issuer on 04/15/2022. The filer reports three recent sales by Panteha Dixon in the past three months: 1,330 shares on 08/15/2025 (gross proceeds $105,203), 1,273 shares on 07/15/2025 (gross proceeds $93,794.64), and 1,283 shares on 06/16/2025 (gross proceeds $87,885.50). The form includes the standard representation that the seller has no undisclosed material information.

Positive

• Full disclosure of planned sale including broker, amount, exchange, and approximate sale date
• Acquisition details provided (performance shares acquired 04/15/2022), supporting traceability
• Recent sales history disclosed with dates and gross proceeds for the past three months

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Form 144 properly discloses a proposed insider sale and recent transactions, reflecting routine compliance with Rule 144.

The filing identifies a proposed sale of 1,500 common shares via Morgan Stanley on NASDAQ and documents three recent sales by the same person in the prior three months with gross proceeds listed. The form states acquisition type (performance shares) and acquisition date, and includes the required attestation regarding undisclosed material information. For compliance reviewers, key items are present: broker, amount, acquisition details, and recent sales history. No material omissions are apparent within the provided content.

Equity Research Associate

TL;DR: Insider sale disclosure is transparent but small in scale; information is routine rather than material to valuation.

The notice discloses the planned disposition and prior sales with gross proceeds amounts, enabling basic tracking of insider liquidity. Acquisition origin as performance shares and the exact dates of prior sales provide context on timing. From an analytical perspective, the quantities and proceeds given in the filing allow straightforward reconciliation with transactional records, but the filing itself contains no earnings or company-operational data that would affect fundamental valuation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1500	101070.00	862100000	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2022	Performance Shares	ISSUER			1500	04/15/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PANTEHA DIXON 1000 N. West Street, Suite 1200 Wilmington DE 19801	Common	08/15/2025	1330	105203.00
PANTEHA DIXON 1000 N. West Street, Suite 1200 Wilmington DE 19801	Common	07/15/2025	1273	93794.64
PANTEHA DIXON 1000 N. West Street, Suite 1200 Wilmington DE 19801	Common	06/16/2025	1283	87885.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for MRVL propose to sell?

The notice proposes the sale of 1,500 common shares of Marvell Technology, Inc.

When and where is the proposed sale scheduled for MRVL shares?

The approximate date of sale is 09/15/2025 and the sale is listed on NASDAQ via Morgan Stanley Smith Barney LLC.

How were the shares to be sold acquired?

The 1,500 shares were acquired as performance shares from the issuer on 04/15/2022.

Did the filer report recent sales of MRVL stock?

Yes. Panteha Dixon reported selling 1,330 shares on 08/15/2025 (gross proceeds $105,203), 1,273 on 07/15/2025 (gross proceeds $93,794.64), and 1,283 on 06/16/2025 (gross proceeds $87,885.50).

Does the Form 144 include the seller's compliance attestation?

Yes. The form includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.